Browse Studies — Arctuva

Phase 4

A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Evaluating Placental Derived Allografts and Standard of Care in the Treatment of Nonhealing Diabetic Foot Ulcers Using Matched Controls

The goal of this study is to determine the between-arm difference in the proportion of subjects achieving complete closure of nonhealing diabetic foot ulcers w…

Diabetic Foot UlcerDFUDiabetic Foot Ulcer (DFU)+4 more

Estimated

~$10 – $8,750

Sequence LifeScience, Inc.NCT07086443

Observational

A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Evaluating PURION Processed Lyophilized Human Amnion/Chorion Membrane (ppLHACM) and Standard of Care Versus Standard of Care Alone in the Treatment of Nonhealing Diabetic Foot Ulcers

This study will evaluate two human amnion/chorion membrane (ppLHACM) products and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic…

Diabetic Foot UlcerDiabetic FootFoot Ulcer Due to Type 2 Diabetes Mellitus+2 more

Estimated

~$10 – $8,750

MiMedx Group, Inc.NCT06600724

Phase 4

A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

A multicenter, prospective, controlled clinical trial evaluating the efficacy of a single layer placental-based allograft and standard of care in the managemen…

Diabetic FootFoot UlcerUlcer Foot+4 more

Estimated

~$10 – $8,750

Applied Biologics, LLCNCT07159282